Snowball logo
logo
ALLO_logo

Allogene Therapeutics, Inc

ALLO β€’ NASDAQ
$1.69-$0.04Β  (2.31%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
38.490.2430.0950.022-4.64
COGS
13.0616.7314.213.6412.36-
Gross Profit
38.490.2430.0950.022(12.36)(32.45)
Operating Expenses & Income
Operating Income
(255.8)(335.4)(327.7)(273.2)(206.9)(180.3)
Total Operating Expenses
294.3335.7327.8273.2194.6147.9
R&D Expenses
220.2256.4242.9192.3150.2119.7
Selling General & Admin Expenses
74.1179.3171.6765.256.7862.44
Earnings from Continuing Operations
Interest Expense
(10.45)(17.11)(17.11)(0.181)(1.075)(1.3)
Interest Income
1.7144.56614.820.1519.2915.81
Income Tax Expense
(12.17)(2.817)(2.817)0.443--
Net Income
Net Income
(244.8)(329.8)(327.3)(257.6)(190.9)(165.5)
Supplemental
EBIT
(255.8)(335.4)(327.3)(257)(189.8)(164.2)
EBITDA
(245.3)(321.2)(313.1)(243.3)(177.5)(152.5)
In millions of USD, except % and values per 1 share